| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |